Profiling Detection and Validation of Six Sartan Substances in Human Urine by LC-MS/MS
Abstract Six sartan substances including telmisartan, losartan, valsartan, irbesartan, olmesartan, and candesartan were selected in this work. A simple and sensitive liquid chromatography–tandem mass spectrometry method was developed and validated to simutaniously detect six drugs. Linearity, LOD, and LOQ were satisfied for routine quantitative and qualitative detection. The linearity ranged from 2 to 1000 ng/mL with the determination coefficient more than 0.98. The intra-day and inter-day precisions were all below 27.5%. All the recoveries were above 80%, and matrix effects were between 25 and 120%. Profiling detection of six sartan substances in human urine was also developed after administration. Irbesartan urinary metabolic pathway was firstly investigated by liquid chromatography quadruple time-of-flight mass spectrometry using full scan and targeted tandem mass spectrometry techniques. Fifteen urinary metabolites of irbesartan were identified and characterized, and ten of them were firstly reported..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Journal of analytical chemistry - 78(2023), 8 vom: Aug., Seite 1041-1054 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hong, Yu [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© Pleiades Publishing, Ltd. 2023. ISSN 1061-9348, Journal of Analytical Chemistry, 2023, Vol. 78, No. 8, pp. 1041–1054. © Pleiades Publishing, Ltd., 2023. |
|---|
| doi: |
10.1134/S1061934823080063 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05261462X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05261462X | ||
| 003 | DE-627 | ||
| 005 | 20231222064645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230803s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1134/S1061934823080063 |2 doi | |
| 035 | |a (DE-627)SPR05261462X | ||
| 035 | |a (SPR)S1061934823080063-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hong, Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Profiling Detection and Validation of Six Sartan Substances in Human Urine by LC-MS/MS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Pleiades Publishing, Ltd. 2023. ISSN 1061-9348, Journal of Analytical Chemistry, 2023, Vol. 78, No. 8, pp. 1041–1054. © Pleiades Publishing, Ltd., 2023. | ||
| 520 | |a Abstract Six sartan substances including telmisartan, losartan, valsartan, irbesartan, olmesartan, and candesartan were selected in this work. A simple and sensitive liquid chromatography–tandem mass spectrometry method was developed and validated to simutaniously detect six drugs. Linearity, LOD, and LOQ were satisfied for routine quantitative and qualitative detection. The linearity ranged from 2 to 1000 ng/mL with the determination coefficient more than 0.98. The intra-day and inter-day precisions were all below 27.5%. All the recoveries were above 80%, and matrix effects were between 25 and 120%. Profiling detection of six sartan substances in human urine was also developed after administration. Irbesartan urinary metabolic pathway was firstly investigated by liquid chromatography quadruple time-of-flight mass spectrometry using full scan and targeted tandem mass spectrometry techniques. Fifteen urinary metabolites of irbesartan were identified and characterized, and ten of them were firstly reported. | ||
| 700 | 1 | |a He, Genye |4 aut | |
| 700 | 1 | |a Lu, Jianghai |4 aut | |
| 700 | 1 | |a Xu, Youxuan |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of analytical chemistry |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 2000 |g 78(2023), 8 vom: Aug., Seite 1041-1054 |w (DE-627)SPR013433083 |w (DE-600)2057336-4 |x 1608-3199 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2023 |g number:8 |g month:08 |g pages:1041-1054 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1134/S1061934823080063 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2023 |e 8 |c 08 |h 1041-1054 | ||